Meeting ReportOncology, Clinical Diagnosis Track

Early initiation of Lu-177 PSMA radioligand therapy prolongs overall survival in metastatic prostate cancer

Harshad Kulkarni, Christiane Schuchardt, AVIRAL SINGH, Thomas Langbein and Richard Baum
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 529;

Article Information

vol. 59 no. supplement 1 529
Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 23, 2018.
Copyright & Usage 
© 2018

Author Information

  1. Harshad Kulkarni1,
  2. Christiane Schuchardt1,
  3. AVIRAL SINGH1,
  4. Thomas Langbein1 and
  5. Richard Baum1
  1. 1THERANOSTICS Center for Molecular Radiotherapy Zentralklinik Bad Berka Bad Berka Germany

Statistics from Altmetric.com

Cited By...

Article usage

Article usage: May 2018 to May 2023

AbstractFullPdf
May 2018500
Jun 201820200
Jul 201831800
Aug 20189300
Sep 201834600
Oct 201859800
Nov 201842700
Dec 201861500
Jan 201976700
Feb 201954100
Mar 201954300
Apr 201936200
May 201940700
Jun 201940500
Jul 201951700
Aug 201942200
Sep 201930100
Oct 201915400
Nov 201911200
Dec 20197800
Jan 20207400
Feb 202013800
Mar 202012300
Apr 20208800
May 20204300
Jun 20203200
Jul 20201900
Aug 20202100
Sep 20205700
Oct 20205700
Nov 20205200
Dec 20206300
Jan 20217700
Feb 202110800
Mar 202112700
Apr 202113400
May 20217200
Jun 20218100
Jul 202111400
Aug 20218600
Sep 20217500
Oct 20214600
Nov 20218200
Dec 20216900
Jan 202213100
Feb 20224800
Mar 20225200
Apr 20227600
May 20228100
Jun 20223700
Jul 202215100
Aug 20223700
Sep 20224500
Oct 20225900
Nov 20226900
Dec 20225000
Jan 202313100
Feb 20235700
Mar 20236800
Apr 20234000
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 59, Issue supplement 1
May 1, 2018
Article Alerts
Email Article
Citation Tools
Bookmark this article

Jump to section